Tim Tyson, Chairman and CEO of TriRx, met with David Alvaro from Pharma's Almanac TV to discuss the future of innovation following the pandemic. They cover the shift in public perception of pharma and drug manufacturing companies, the future of collaboration, and how the pandemic has emphasized pharma's core competency: innovation.